Sequence-Controlled Peptoid Hydrogels for Neuronal Trans-Differentiation: A Synthetic Biomaterials Approach in Future Neuroregenerative Research

Abstract

Peptide-based hydrogels stimulate stem cell differentiation into neurons, improve neuroprotection, and aid in spinal cord/brain injury repair by moderating inflammatory responses and activating endogenous healing pathways. Peptoid-based hydrogels, with superior enzymatic stability and tunable properties, offer a promising alternative but remain unexplored in neurodegenerative therapies. Thus, future study should focus on optimizing peptoid-based hydrogel formulations, which could considerably progress neuroregenerative therapies in neuroscience research.

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Opinion
Submitted
26 Jul 2025
Accepted
27 Sep 2025
First published
29 Sep 2025
This article is Open Access
Creative Commons BY license

RSC Med. Chem., 2025, Accepted Manuscript

Sequence-Controlled Peptoid Hydrogels for Neuronal Trans-Differentiation: A Synthetic Biomaterials Approach in Future Neuroregenerative Research

D. C. Yamanur, P. Paudel and P. K. GHARAI, RSC Med. Chem., 2025, Accepted Manuscript , DOI: 10.1039/D5MD00610D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements